arrow
J

Julien Péron

Université Claude Bernard Lyon 1
H指数:33
被引数:3,238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patients’ and oncologists’ perspectives on shared decision-making and treatment communication in HR+/HER2 − advanced breast cancer: a multicountry survey

HR+/HER2−晚期乳腺癌患者和肿瘤科医师对共同决策和治疗沟通的看法:一项多国调查

2026-09-100
OA
Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)

转移性乳腺癌患者关注的生活质量问题:欧洲癌症研究与治疗组织转移性乳腺癌模块(EORTC QLQ-MBR)的第一阶段和第二阶段开发

Breast
IF7.9
2026-09-050
OA
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

EURACAN框架下SPECTA Arcagen研究中的分子谱分析与个性化医学,与法国基因组医学2025计划中AURAGEN平台在腹膜间皮瘤中的比较

2026-05-180
OAAI
Identifying High-Risk Relapse in Early-Stage I–II Ovarian Cancer Using the CA-125 ELIMination rate constant K (KELIM) Score: A GCIG Individual Patient Data Meta-analysis

使用CA-125 ELIMination率常数K (KELIM)评分识别早期I-II期卵巢癌的高复发风险:一项GCIG个体患者数据荟萃分析

2025-10-100
OAAI
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients

评估弥漫性恶性腹膜间皮瘤患者行完全细胞减灭术联合温热腹腔化疗(HIPEC)后的年度复发风险

2025-09-260
PRE
ASO Visual Abstract: Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Colorectal Cancer Patients with Surgical History

ASO视觉摘要:术前腹膜MRI:在具有手术史的大肠癌患者中,完全细胞减灭术用于突出潜在隐匿病灶的实用性

2025-09-090
PRE
Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History

术前腹膜MRI:用于结直肠癌有手术史患者的完全细胞减灭术,以突出潜在隐匿病灶的实用性

2025-08-060
OAAI
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first- line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
2023-09-018
OAAI
ASO Visual Abstract: Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes - A Retrospective Study
2023-03-070
PRE